An observational study in Asthma, sponsored by University Hospital, Lille. Terminated at 5 sites in France. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2023-01-26.
Sponsored by University Hospital, Lille · Observational
Breathlessness is a symptom of asthma that occurs in relation with lower airway obstruction. However, this sensation is not specific of asthma and may be the expression of other disorders. In particular, it can testify to anxiety or hyperventilation, two disorders frequently associated with asthma. The systematic interpretation of dyspnea as a manifestation of asthma in asthmatic patients may lead to an inappropriate increase in asthma controllers.
Identifying the cause of dyspnea in asthmatic patients (airway obstruction, anxiety or hyperventilation) is therefore crucial for the clinician.
This could be facilitated by a multidimensional assessment of dyspnea, evaluating the kind of sensation felt by the patient (for example chest tightness, air hunger etc.) and emotions associated to respiratory sensations (for example anxiety, fear etc.).
The objectives of this project are to assess: (1) the sensory and affective dimensions of dyspnea in asthma and, (2) their connection to asthma control, anxiety and depression.
3,921 studies on the registry are indexed under Asthma; 507 are open to participants now.
This study's enrollment of 133 is below the median of 150 across 970 observational studies indexed under Asthma.
Browse Asthma studies →University Hospital, Lille is the lead sponsor of 625 studies on the registry; 141 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Asthmatic patients reporting breathlessness
Diagnosis of asthma confirmed by:
oReversibility of airway obstruction after bronchodilators (400 µg of salbutamol): FEV 1 increases by> 200 mL and> 12% compared to baseline
Exclusion Criteria:
Asthmatic patients
Other: Questionnaire
MultiDimensional Profile (MDP), Anxiety-Depression Hospital Scale (HADs), Nijmegen
Description of the sensory and affective dimensions of dyspnea
MultiDimensional Profile (MDP) scores QS and A2
Time frame: At baseline
Association between dyspnea intensity and asthma control
Correlation between MDP scores QS and A2 and ACQ-5 Correlation between MDP scores QS and A2 and ACQ-5
Time frame: At baseline
Association between dyspnea intensity and anxiety
Correlation between MDP scores QS and A2 and anxiety score HAD-A
Time frame: At baseline
Association between dyspnea intensity and hyperventilation
Correlation between MDP scores QS and A2 and the Nijmegen score
Time frame: At baseline
Association between change in dyspnea intensity and in asthma control
Correlation between change in MDP scores QS and A2 and change in ACQ-5
Time frame: Difference between baseline and 6 months
Association between change in dyspnea intensity and in anxiety
Correlation between change in MDP scores QS and A2 and change in HAD-A score
Time frame: Difference between baseline and 6 months
Association between change in dyspnea intensity and in hyperventilation
Correlation between change in MDP scores QS and A2 and change in the Nijmegen score
Time frame: Difference between baseline and 6 months
Plan to share: No
No publications or documents are linked to this record.
This study is terminated, as verified in Jan 2023. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
University Hospital, Lille